New York State leading the way
Fortunately, we’ve already begun to see a proactive approach from one state, as Governor Cuomo of New York recently announced a groundbreaking initiative to detect, track, and manage antimicrobial-resistant infections at healthcare institutions statewide. This first-of-its-kind collaboration will produce a digital health and precision medicine platform that connects NY healthcare institutions to the NY Department of Health, and uses genomic microbiology for statewide surveillance and control of antimicrobial resistance.
The goal of the program is to improve patient outcomes while also saving healthcare dollars by integrating real-time epidemiologic surveillance with rapid delivery of resistant results to caregivers via web-based mobile platforms. Upon successful completion of a demonstration period a statewide rollout could follow, creating a blueprint for all other U.S. states to follow in the fight against antimicrobial-resistant infections.
About the author: Evan Jones is the CEO of OpGen Inc., a pioneering informatics and genomic analysis company providing complete solutions for patient, hospital, and network-wide infection prevention and treatment.Back to HCB News
